Financial results - SOLIUS PHARM SRL

Financial Summary - Solius Pharm Srl
Unique identification code: 33724280
Registration number: J23/3080/2014
Nace: 4773
Sales - Ron
674.904
Net Profit - Ron
79.162
Employee
5
The most important financial indicators for the company Solius Pharm Srl - Unique Identification Number 33724280: sales in 2023 was 674.904 euro, registering a net profit of 79.162 euro and having an average number of 5 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.
Sales - Ron025K28K154K231K359K332K479K585K675K20142014201520152016201620172017201820182019201920202020202120212022202220232023

Sales, Profit, Employees, Debts, Capitals, Financial Results - Solius Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 0 25.058 28.051 153.776 231.388 359.140 332.494 479.294 585.403 674.904
Total Income - EUR 0 25.058 28.051 153.789 231.548 359.217 332.585 479.327 585.403 674.904
Total Expenses - EUR 1.253 37.119 45.409 140.887 209.621 304.024 300.216 404.633 514.957 583.066
Gross Profit/Loss - EUR -1.253 -12.061 -17.358 12.902 21.927 55.193 32.369 74.694 70.447 91.837
Net Profit/Loss - EUR -1.253 -12.827 -17.639 11.364 19.611 51.588 29.295 70.474 64.707 79.162
Employees 1 2 2 1 3 4 3 3 4 5
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales increased by 15.6%, from 585.403 euro in the year 2022, to 674.904 euro in 2023. The Net Profit increased by 14.651 euro, from 64.707 euro in 2022, to 79.162 in the last year.
Sales - Ron025K28K154K231K359K332K479K585K675K20142014201520152016201620172017201820182019201920202020202120212022202220232023
Net Profit - Ron-1.3K-13K-18K11K20K52K29K70K65K79K20142014201520152016201620172017201820182019201920202020202120212022202220232023
Employees122134334520142014201520152016201620172017201820182019201920202020202120212022202220232023

Check the financial reports for the company - Solius Pharm Srl

Rating financiar

Financial Rating -
Solius Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Solius Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Solius Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Solius Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Solius Pharm Srl - CUI 33724280

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 831 31 0 40 5.573 3.800 2.085 28.298 20.521
Current Assets 360 21.784 33.083 64.253 82.751 96.771 119.445 192.261 214.228 354.489
Inventories 0 19.052 28.431 45.769 71.377 90.705 104.233 119.366 169.416 281.338
Receivables 297 2.542 3.916 1.964 6.257 2.974 9.398 29.990 39.763 63.250
Cash 63 190 737 16.520 5.117 3.092 5.814 42.905 5.049 9.902
Shareholders Funds -1.208 -14.045 -31.540 -19.643 329 51.910 80.221 148.916 64.756 143.721
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 1.568 36.660 64.655 83.895 82.461 50.433 43.024 45.430 177.771 231.289
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 354.489 euro in 2023 which includes Inventories of 281.338 euro, Receivables of 63.250 euro and cash availability of 9.902 euro.
The company's Equity was valued at 143.721 euro, while total Liabilities amounted to 231.289 euro. Equity increased by 79.162 euro, from 64.756 euro in 2022, to 143.721 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Solius Pharm Srl

Review
0.00
(0 reviews)
5 stars
(0)
4 stars
(0)
3 stars
(0)
2 stars
(0)
1 star
(0)

Comments - Solius Pharm Srl

Similar services useful for checking companies and business development.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.